Key facts
- This page summarizes David M. Berman's Form 4 filing for Immunocore Holdings plc (IMCR).
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Mar 2024, 16:15.
David M. Berman - 28 Feb 2024 Form 4 Insider Report for Immunocore Holdings plc (IMCR)
- Reporting relationship
- HEAD OF R&D
- Issuer ticker
- IMCR
- Reported as of
- 28 Feb 2024
- Net transaction value
- -$1,866,711
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2024, 16:15:14 UTC
- Prior SEC filing
- 28 Feb 2024
- Next SEC filing
- 19 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily Hepworth, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David M. Berman filed Form 4 for Immunocore Holdings plc (IMCR) on 01 Mar 2024.
Change
- Previous filing in this sequence was filed on 28 Feb 2024.
- Current net transaction value: -$1,866,711.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMCR
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $637,447
- Shares
- +36,509
- Change %
- Price
- $17.46*
- Shares after
- 36,509
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
IMCR
transaction
Ordinary Shares
Sale
- Transaction value
- $1,142,609
- Shares
- -16,900
- Change %
- -46%
- Price
- $67.61
- Shares after
- 19,609
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
IMCR
transaction
Ordinary Shares
Sale
- Transaction value
- $514,372
- Shares
- -7,472
- Change %
- -38%
- Price
- $68.84
- Shares after
- 12,137
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F3
IMCR
transaction
Ordinary Shares
Sale
- Transaction value
- $762,637
- Shares
- -10,937
- Change %
- -90%
- Price
- $69.73
- Shares after
- 1,200
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F4
IMCR
transaction
Ordinary Shares
Sale
- Transaction value
- $84,540
- Shares
- -1,200
- Change %
- -100%
- Price
- $70.45
- Shares after
- 0
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMCR
transaction
Derivative
Employee Share Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -36,509
- Change %
- -12%
- Price
- $0.000000
- Shares after
- 271,790
- Date
- 28 Feb 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 36,509
- Exercise price
- $17.46
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2023.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.08 to $68.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.26 to $69.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.26 to $70.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.42 to $70.48 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Footnote F6
Immediately exercisable.